INMD, IL0011595993

InMode launches Morpheus8 Cool: InMode stock sits below USD 16 target

Published on 10/13/2026 at 01:49 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Morpheus8 Cool was introduced in September 2026 for aesthetic procedures. InMode stock last stood at EUR 12.82 on October 12, 2026, while analysts target USD 16.00.

  • InMode launched Morpheus8 Cool in September 2026, according to a recent company comparison page.
  • MarketBeat reported a seven-analyst Hold consensus and a USD 16.00 average target on October 5, 2026.
  • Second-quarter 2026 revenue reached USD 95.59 million versus USD 94.89 million consensus, while net income was USD 17.06 million.
  • The last Lang & Schwarz price was EUR 12.82 on October 12, 2026 at 10:57 p.m. CEST.
INMD, IL0011595993, Illustration mit AI erstellt.
INMD, IL0011595993, Illustration mit AI erstellt.

InMode launched Morpheus8 Cool in September 2026, while InMode stock sat 11.89 percent below the USD 16.00 average analyst target reported by MarketBeat on October 5, 2026. The product launch was referenced by Pluang on October 10, 2026.

Product expansion meets cautious ratings

Morpheus8 Cool adds to InMode's portfolio of energy-based medical aesthetic systems, which includes platforms for skin rejuvenation, body contouring and other soft-tissue procedures. The September 2026 launch gives the company a current product development angle as analysts maintain a cautious overall stance.

MarketBeat said seven research firms assigned five Hold ratings, one Sell rating and one Buy rating on October 5, 2026. The USD 16.00 average target was set against a recent USD 14.09 share price in the same report, making the target 13.55 percent above that reference price.

Revenue beat expectations in Q2

For the quarter ended June 30, 2026, InMode generated USD 95.59 million in revenue and USD 17.06 million in net income, according to Business Quant. Revenue exceeded the USD 94.89 million consensus estimate by USD 0.70 million, while revenue rose from USD 82.02 million in the first quarter of 2026 to USD 95.59 million in the second quarter.

The operating margin was 13.00 percent in the second quarter of 2026, compared with 12.00 percent in the first quarter. Net income also increased from USD 11.56 million to USD 17.06 million over the same period, giving the product launch a profitable operating backdrop.

Stock remains below the analyst target

The last available Lang & Schwarz price was EUR 12.82 on October 12, 2026 at 10:57 p.m. CEST. MarketBeat listed a USD 12.72 to USD 16.74 52-week range on October 5, 2026, placing the latest reported USD 14.09 reference inside that band.

The further course of trading is shown by the continuously updated real-time quote of InMode stock.

InMode stock facts

  • Company: InMode Ltd.
  • ISIN: IL0011595993
  • Ticker: INMD
  • Primary exchange: Nasdaq
  • Price Lang & Schwarz as of October 12, 2026, 10:57 p.m. CEST: EUR 12.82
  • Market capitalization: USD 822.0 million as of October 12, 2026
  • 52-week range: USD 12.72-16.74 as of October 5, 2026
  • Sector / Industry: Healthcare / Medical Devices

Market context: Market report Nasdaq Composite.

More news and analyses on InMode stock

Disclaimer...

en | IL0011595993 | INMD | boerse | 70306969 | bgmi